Fexagratinib

**Semantic type:** Pharmacologic Substance

**Definition:** An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. fexagratinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation, differentiation and survival.

**Synonyms:** - ABSK-091 - ABSK091 - AZD4547 - FEXAGRATINIB - FGFR Inhibitor AZD4547 - KB-74810